Patients with liver metastases from breast cancer have a shorter survival cycle, and the main treatment options are chemotherapy, radiation therapy, targeted therapy, endocrine therapy, surgery, and more.
Liver metastases from breast cancer are advanced breast cancers that can cause liver insufficiency and have a poor prognosis with a low long-term survival rate. The following treatment options are available for breast cancer liver metastases:
1. Chemotherapy: Chemotherapy is the common treatment for breast cancer liver metastasis. Chemotherapy is a systemic treatment, and some chemotherapy can inhibit tumor cells and reduce tumor size.
2. Endocrine therapy: Endocrine therapy is available for those with positive estrogen receptors.
3. Targeted therapy: Targeted therapy is feasible for HER-2-positive patients.
4. Surgery: Breast cancer metastasis to the liver is a solitary mass, and surgical excision and ablation therapy are recommended for the treatment of the lesion.
5. Radiotherapy: chemotherapy combined with radiotherapy can prolong the survival cycle.
6. Liver-protective therapy: Patients with liver metastases may have abnormal liver function. During chemotherapy, it is necessary to protect liver function, reduce symptoms and chemotherapy side effects, control disease progression, enhance physical fitness, improve their immunity and resistance to disease, improve the quality of survival and prolong survival period.
Although many breast cancer liver metastases have a short survival time, many patients have reached a 5-year clinical cure with the disappearance of metastases after aggressive treatment.